Hypercholesterolemia is a major risk factor for the development and progression of cardiovascular diseases including atherosclerosis. A major active ingredient scutellarin, from the plant Erigeron breviscapus was investigated for its hypocholesterolemic and atheroscleroprotective effects (30 and 100 mg/kg/day, p.o.). The serum lipid profile (total cholesterol, triglycerides, high density lipoprotein cholesterol and low density lipoprotein cholesterol) was monitored and aortic functions in Sprague-Dawley rats fed with normal diet, atherogenic diet or atherogenic diet plus oral administration of either scutellarin or simvastatin (a positive control) were tested. It was found that scutellarin markedly attenuated the increased serum total cholesterol induced by atherogenic diet. It caused a significant reduction in the atherogenic index. In addition, scutellarin administration could significantly enhance acetylcholine-induced nitrate/nitrite production, increase the gene expression of endothelial nitric oxide synthase and improve acetylcholine-induced endothelium-dependent vasorelaxation in rat isolated aortas. These data revealed that scutellarin could reduce the atherogenic properties of dietary cholesterol in rats. However, whether scutellarin's atheroscleroprotective potential targets endothelial function directly or indirectly on its antioxidative activity remains to be determined.
Introduction
Atherosclerosis is the leading cause of death in developed countries and the incidence rate is increasing in other parts of the world [1, 2] . Hypercholesterolemia (high blood total cholesterol) is a dominant risk factor for the development and progression of atherosclerosis and other related cardiovascular diseases which have emerged as a major health problem in many countries [2, 3] . A high cholesterol diet is a major contributor to an unbalanced lipoprotein metabolism and associates with an increased prevalence of atherosclerosis [3] .
In hypercholesterolemia and atherosclerosis, the physiological activity of nitric oxide (NO) is reduced and this resulted in impairment of the endothelium-dependent vasodilation, platelet aggregation enhancement and increased endothelial adhesiveness for monocytes [4] . Endothelial dysfunction is recognized as the basic mechanism for initiation and maintenance of atherosclerosis [5] . Therefore, the protection of endothelial integrity by elimination of certain risk factors via lipid lowering agents has been proven to be effective in restoring endothelial function and in slowing the progress of the disease [6] .
Scutellarin, 7-(-D-glucopyranuronosyloxy)-5,6-dihydroxy-2-(4-hydroxyphenyl)-4-H-1-benzopyran-4-one (C 21 H 18 O 12 ) ( Fig. 1) , is one of the active components isolated from a perennial wild plant distributed in southwest China, Erigeron breviscapus (Vant.)
Hand.-Mazz. (Dengzhanxixin), which belongs to the family of Compositae and has been used in clinical settings to treat cerebrovascular accident patients for many years [7] . In recent years, it was reported that scutellarin possessed anticoagulatory [8] , antioxidative [9] , anti-inflammatory [10], neuroprotective [11] , vasorelaxation [12] as well as cardiovascular and cerebrovascular ischemia protective effects [13, 14] . Despite the broad therapeutic uses of Erigeron breviscapus, there have been no reports on its effects on the reduction of lipid levels and atheroscleroprotection.
Therefore, an investigation was studied on scutellarin for any effect on high cholesterol diet-induced hypercholesterolemic rats, in particular the serum lipid profile [total cholesterol, triglycerides, high density lipoprotein cholesterol (HDL) and low density lipoprotein cholesterol (LDL)]. To investigate the protective role of scutellarin treatment under hypercholesterolemic condition, further investigations were carried out on the endothelium-dependent vasorelaxation, acetylcholine-induced nitrate/nitrite production [presumably NO production] and endothelial nitric oxide synthase (eNOS) mRNA expression of isolated aortas from rats with or without treatment with scutellarin. The effect of simvastatin, a known hypocholesterolemic and hypolipidemic drug, was also used for comparison.
Materials and Methods

Chemicals
Scutellarin was purchased as a yellow powder (>98% purity, formula weight 464.4) from Xi'an Guanyu Bio-Technique Co. Ltd (Xi'an, China) while simvastatin 20 mg tablets (10% purity, the content was confirmed by HPLC) were purchased from Hangzhou MSD Pharmaceutical Co. Ltd. (Hangzhou, China). Phenylephrine, acetylcholine, N ω -nitro-L-arginine methyl ester (L-NAME), indomethacin and neostigmine were purchased from Sigma Chemicals Co. (St. Louis, MO, USA). NO kit was from Nanjing Keygen Biotech. Co. Ltd. (Nanjing, China). All the other chemicals used were of analytical grade.
Animals and experimental treatment
Male Sprague-Dawley rats (170 ± 10 g), supplied by Guangdong Provincial Medical Laboratory Animal Center (Guangzhou, PR of China), were housed separately (4 animals/cage) under a temperature controlled (25 ± 2 °C) room with a regular 12 hr light: 12 hr dark cycle. After one week, the rats were randomly assigned to one of five experimental groups (n = 8) for an additional 38 days. These groups were control group (Control), high cholesterol diet group (HCD), simvastatin (10 mg/kg/day, p.o.) treated group (SIM), low dose scutellarin (30 mg/kg/day, p.o.) treated group (SL) and high dose scutellarin (100 mg/kg/day, p.o.) treated group (SH). The control group was fed with standard normal rat chow with protein (~14%), fat (~10%) and carbohydrate (~76%) while the other groups were fed with HCD, which is a standard rat chow supplemented with 1% cholic acid, 2% pure cholesterol and 5.5% oil. The rats were administered with distilled water or their corresponding drugs by oral gavage (20 mL/kg) once every morning for 38 days. At the end of the experimental period, the rats were fasted overnight and killed by cervical dislocation. Blood samples and aortas were then collected for further analysis. All experiments were approved by the Ethical Committee of the Hong Kong Polytechnic University.
Analysis of lipid levels in blood samples
Immediately after cervical dislocation, blood was collected in chilled centrifuge tubes by cardiac puncture. The blood was then centrifuged (4500 rpm) at 4 °C for 15 min and serum was collected. Total serum cholesterol, triglycerides, LDL and HDL were measured by using the Keygen's reagents.
Isolation of thoracic aorta
At the end of the treatment period, the rats were sacrificed and their thoracic aortas were immediately placed in 4 °C Tyrode's solution of the following composition: NaCl 118 mM, KCl 4.7 mM, KH 2 PO 4 1.2 mM, NaHCO 3 25 mM, glucose 11 mM, CaCl 2 2.5 mM, and MgSO 4 1.2 mM. The isolated aorta from each animal was cut into three ring segments with any fat and connective tissue removed. One ring from each aortic preparation was used for isometric tension measurement (aortic ring ~3 mm), in vitro nitrate/nitrite production (aortic ring ~15 mm) and real-time PCR analysis (aortic ring ~15 mm).
Measurement of the isometric tension of the isolated thoracic aorta
One of the ring segments was mounted in 5 ml organ baths filled with Tyrode's solution (37 °C, gassed with 95% O 2 and 5% CO 2 mixture), under passive tension of 1.2 g for 60 min. After 60 min of equilibration, the aortic rings were challenged with 60 mM KCl twice to ensure a suitable contractile set up of the preparation. The contractile response (isometric tension, in g) was measured. To investigate the relaxant effects of acetylcholine on isolated aorta, the preparations were pre-contracted with 1 M phenylephrine in the presence of 1 M indomethacin (a nonselective cyclo-oxygenase inhibitor) and 1 M neostigmine (an anticholinesterase). After a steady-state contraction was established, cumulative concentrations (10 nM -10 M) of acetylcholine were added to the organ bath.
In vitro nitrate/nitrite production in the isolated thoracic aorta
To evaluate the endothelial damage in blood vessels caused by high cholesterol diet, in vitro nitrate/nitrite production in the aortic ring was tested to estimate NO production.
The isolated aortas were washed twice with Tyrode's solution, and then cut into 15mm segments (weight = 0.03 -0.04 g). The segments were incubated in a 24-well plate (containing 2 mL Tyrode's solution per well) with 1 M acetylcholine and 1 M neostigmine. After incubation (37 °C) for 2 hr, each segment was blotted dry and weighed and the incubated culture solution of each well was collected in a separate microcentrifuge tube. The solution of each tube was subsequently dried by vacuum freeze-drying and the resulting pellets were re-dissolved with 300 L of distilled water.
Nitrate/nitrite levels were measured using the Keygen's NO kit. The absorbance was determined using the spectrophotometer at 540 nm. The concentrations of nitrate/nitrite were calculated following the instruction of the kit.
Real-time polymerase chain reaction analysis
Isolated thoracic aortas were homogenized and total RNA was extracted using Trizol reagent (Life Technologies Inc., Rockville, MD, USA) for the determination of gene expression levels in various groups. 3.5 g of total RNA was reverse transcribed into cDNA using RevertAid™ first strand cDNA synthesis kit (Fermentas). Table 1) . Expression levels of the cDNA of interest were related to an internal standard:
housekeeping gene (GAPDH), to correct for differences in quantity and quality between different RNA samples.
Statistical analysis
Data was expressed as means ± S.E.M. and n denotes the number of replications for each data point. After validation of each parameter for homogencity of variance, the differences between groups were assessed by one-way analysis of variance using SPSS (Version 12) software package for Windows (Chicago, IL, USA). Post hoc testing was performed for intergroup comparisons using the least significance difference test; with P values of < 0.001, < 0.01 and < 0.05 are indicated in the figures or tables.
Results
The lipid profiles: serum total cholesterol, triglycerides, HDL and LDL from various rat groups are summarized in Table 2 Further analysis of the impact of serum lipid profiles on the progression of atherosclerosis, the atherogenic index [(total serum cholesterol  HDL) / HDL] which measures coronary heart disease risk was calculated. It was found that elevated atherogenic index was observed in the HCD. There was a significant decrease in the atherogenic indexes in both the SIM and SH (Fig. 2) which suggested the atheroscleroprotective potential of simvastatin or scutellarin in the current experimental setting. The atherogenic indexes were 2.69 ± 0.32 in the SIM and 2.58 ± 0.13 in the SH as compared to the HCD with 3.63 ± 0.26. The indexes for both the SIM and SH were close to the level of the control group (2.26 ± 0.32).
To evaluate the protective effect of drug administration on vascular endothelial activity, the thoracic aorta (with intact endothelium) was isolated for various analyses. When phenylephrine (1 M)-induced contraction reached a steady condition, acetylcholine was added cumulatively to the aortic preparation. Acetylcholine elicited a concentration (10 nM  10 M)-dependent aortic relaxation of various groups of rats with ~55  80% maximum relaxation at 10 M (n = 6  8) (Fig. 3) . However, a significant smaller magnitude of relaxation caused by acetylcholine was observed from HCD rats compared to those observed in other groups. Scutellarin (30 mg/kg/day & 100 mg/kg/day) dose dependent improved the acetylcholine-induced relaxation in rats with high cholesterol diet. There was amelioration in the acetylcholine-induced relaxation in animals treated with scutellarin (100 mg/kg/day) and simvastatin (10 mg/kg/day).
The effect of drug treatments on high cholesterol diet-induced damage on aortic endothelial cells was also investigated. The isolated aortic rings from various groups were tested with regard to their effect on nitrate/nitrite production. Without acetylcholine
(1 M), aortic rings released undetectable levels of nitrate/nitrite after 2 hr incubation (data not shown). When acetylcholine (1 M) was added to the incubation medium, nitrate/nitrite production in control group dramatically increased to 0.86 ± 0.21nmol/mg of aortic tissue for the 2 hr incubation period. The effect of acetylcholine on nitrate/nitrite production could be abolished by a NOS inhibitor, L-NAME (20 M) (data not shown).
It was found that high cholesterol diet markedly attenuated nitrate/nitrite production (0.25 ± 0.05 nmol/mg of tissue, P < 0.05). As shown in Fig. 4 , all treatment groups significantly potentiated nitrate/nitrite production. The increase in nitrate/nitrite production for scutellarin was in a dose-dependent manner.
Change in the gene expression of eNOS was also examined (Fig. 5) . The gene expression level of eNOS in the aortas from HCD group was markedly suppressed (P < 0.001);
whereas treatment of simvastatin (10 mg/kg/day) and scutellarin (100 mg/kg/day) could significantly increase eNOS expression level back to the level of control group (1.81 ± 0.324) (P < 0.05). However, animals treated with scutellarin (30 mg/kg/day) showed no significant enhancement in the gene expression of eNOS.
Discussion
This study described for the first time that scutellarin has hypocholesterolimic effect and is orally active. In the present study, we have illustrated that oral scutellarin administration significantly reduced serum total cholesterol and increased serum HDL/LDL ratio. In addition, the elevated atherogenic index induced by atherogenic diet was reversed thus suggesting atheroscleroprotection by scutellarin. Although the testing dosage for scutellarin was up to 100 mg/kg/day, it can be considered as non-toxic for the fact that intraperitoneal LD 50 values in mice is 2402 mg/kg [13] . To evaluate the applicability of the current animal model, simvastatin (positive control) was used. It is a potent hypocholesterolemic and hypolipidemic drug of statin series and is commonly for the treatment of coronary heart disease, hypercholesterolemia and hyperlipidemia [15] . In this study, simvastatin has been shown to improve serum lipid profile and atherogenic index similar to the effects seen with scutellarin. However, the effects of simvastatin in the present study were associated with an increase in HDL level but no change in LDL level in animals fed with atherogenic diet. This is different from the function of statins in lowering LDL. This warrants further study in the current experimental setting.
In the current study, the HCD had abnormal serum lipid levels with significantly increased total cholesterol and LDL but no significant changes in triglyceride and HDL levels. This is consistent with previous studies with similar experimental settings [3,16].
In fact, elevated plasma total cholesterol and LDL levels are significant enough to demonstrate the atherogenic effect of the model since both parameters play a significant In the present study, scutellarin treatment dose dependently improved acetylcholine-induced relaxation on aortic rings. This can be explained by the up-regulation of eNOS RNA expression and/or increase in acetylcholine-induced nitrate/nitrite production, which represented an increase in NO availability. Scutellarin was shown to increase eNOS expression in a rat model of cerebral ischemia/reperfusion [14] . However, whether the vasoprotective effect is due to the up-regulation of eNOS gene, the antioxidative activity of scutellarin or both is presently unclear and awaits further investigation. In the HCD group, eNOS RNA expression was down-regulated in isolated aorta. However, several studies have shown that cardiovascular risk factors, including hypercholesterolemia are associated with an increase rather than a decrease in eNOS expression [27, 28] . The reason for a decrease in NO availability is more likely related to eNOS dysfunction (eNOS uncoupling), which in many cases is resulted from a reduced availability of tetrahydrobiopterin, an essential co-factor for NOS [28] . eNOS uncoupling will lead to superoxide and H 2 O 2 production [29] . The discrepancy in eNOS RNA expression warrants further study. Data are expressed as means ± SEM, n = 5 8. # P < 0.05 represents significant differences when compared with the Control group. *P < 0.05 and **P < 0.01 represent significant differences when compared with the HCD. # P < 0.05 represents significant differences when compared with the Control group. *P < 0.05 represents significant differences when compared with the HCD. Data are expressed as means ± SEM, n = 3 -8.
### p < 0.001 represents significant differences when compared with the Control group.
*p < 0.05 represents significant differences when compared with the HCD group. **p < 0.01 represents significant differences when compared with the HCD group. ***p < 0.001 represents significant differences when compared with the HCD group. 
